15472211000001106: Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)
\UK product\Virtual medicinal product\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)
\UK product\Virtual therapeutic moiety\Gemcitabine\Product containing only gemcitabine in parenteral dose form (medicinal product form)\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)
\UK product\Virtual therapeutic moiety\Gemcitabine\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Gemcitabine\Product containing only gemcitabine in parenteral dose form (medicinal product form)\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Gemcitabine\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Product containing gemcitabine in parenteral dose form (medicinal product form)\Product containing only gemcitabine in parenteral dose form (medicinal product form)\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Gemcitabine\Product containing only gemcitabine in parenteral dose form (medicinal product form)\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Gemcitabine\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Product containing gemcitabine in parenteral dose form (medicinal product form)\Product containing only gemcitabine in parenteral dose form (medicinal product form)\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Gemcitabine\Product containing only gemcitabine in parenteral dose form (medicinal product form)\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Gemcitabine\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Product containing gemcitabine in parenteral dose form (medicinal product form)\Product containing only gemcitabine in parenteral dose form (medicinal product form)\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)
\Medicinal product\Product manufactured as parenteral dose form\Product containing gemcitabine in parenteral dose form (medicinal product form)\Product containing only gemcitabine in parenteral dose form (medicinal product form)\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

54759801000001111 Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

112442301000001113 Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)	Is a	Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)	Has active ingredient	Gemcitabine hydrochloride	false	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)	Has manufactured dose form	Injection	false	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Gemcitabine	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)	Has specific active ingredient	Gemcitabine hydrochloride	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)	Has dispensed dose form	Powder for infusion solution	false	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)	Has basis of strength substance	Gemcitabine	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)	Has dispensed dose form	Powder for conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd) 1 vial	Has AMP	True	Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
54759801000001111	Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceuticals UK Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
112442301000001113	Gemcitabine 200mg powder for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module